WRAPSODY FIRST Study: Treatment of Access Circuit Stenosis in Haemodialysis Patients | Mr Gilbert

Подробнее о видео

Watch on Radcliffe Vascular:

In this short interview, Mr James Gilbert (Oxford University Hospitals NHS Foundation Trust, UK) sits down to discuss the clinical results of the WRAPSODY FIRST Study (NCT03644017), a first-in-human study intended to evaluate the efficacy and safety of the WRAPSODY Stent Graft in the treatment of venous outflow circuit obstructions in patients with renal disease.

Results show that the target lesion patency of the device was encouraging at 6 and 12 months.

Discussion Points:
1. Unmet Needs in Current Stenosis Treatments
2. Studied Device
3. Study Design and Patient Population
4. Key Findings
5. Next Steps
6. Take-home Messages

Recorded remotely from Oxford, 2022.
This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.